CDH1 and prostate carcinoma: Therefore, the ability of prostate cancer cells to utilise E-cadherin to bind to hepatocytes was tested by assessing cell–cell adhesion between adherent hepatocytes and prostate carcinoma cells using the centrifugal assay for cell adhesion (McClay et al, 1981).